MUC1 peptide-loaded dendritic cell vaccine boosts antitumor immunity in pancreatic cancer
MUC1 peptide-pulsed DCs effectively activate specific CTL responses, indicating that DC-based vaccine immunotherapy holds promise for the management of pancreatic cancer.
Authors
- Shuai Fan (ORCID: https://orcid.org/0000-0002-8593-9329)
- Wenzhuo Yang (ORCID: https://orcid.org/0000-0002-8365-9710)
- Zhilan Zhang
- Huiping Xie
- Yuanyuan Jin
- Haodong Chen
- Zelin Zhao
- Zhaoyong Yang
Institutions
- North China University of Science and Technology (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- National Health and Family Planning Commission (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-13
- DOI
- https://doi.org/10.3389/fimmu.2025.1752861
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China